Robert Scott Sharp

US Patent:

6387655, May 14, 2002

Filed:

Dec 19, 1996

Appl. No.:

08/794158

Inventors:

Nancy Gail Mayne - Indianapolis IN
Robert Leon Sharp - Indianapolis IN

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

C07K 14705

US Classification:

435 691, 4352523, 4353201, 530350, 536 235

Abstract:

This invention describes a novel human glutamate receptors, designated HmGluR3. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.

US Patent:

61034754, Aug 15, 2000

Filed:

Feb 26, 1999

Appl. No.:

9/258523

Inventors:

James Paul Burnett - Indianapolis IN
Nancy Gail Mayne - Indianapolis IN
Robert Leon Sharp - Indianapolis IN
Yvonne Marie Snyder - Indianapolis IN

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

C12Q 168

US Classification:

435 6

Abstract:

This invention describes a novel human glutamate receptors, designated mGluR2. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.

US Patent:

62113534, Apr 3, 2001

Filed:

Jun 7, 1996

Appl. No.:

8/660148

Inventors:

James Paul Burnett - Indianapolis IN
Nancy Gail Mayne - Indianapolis IN
Robert Leon Sharp - Indianapolis IN
Yvonne Marie Snyder - Indianapolis IN

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

C12N 1512

US Classification:

536 235

Abstract:

This invention describes two novel human glutamate receptors, designated mGluR5A and mGluR5B. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.

US Patent:

63129450, Nov 6, 2001

Filed:

Mar 7, 1995

Appl. No.:

8/400067

Inventors:

J. Paul Burnett - Indianapolis IN
Nancy G. Mayne - Indianapolis IN
Robert L. Sharp - Indianapolis IN
Yvonne M. Snyder - Indianapolis IN

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

C12N 1512
C12N 1563
C07K 14705

US Classification:

4353201

Abstract:

The present invention provides a human glutamate receptor and related DNA compounds useful not only in assays for potential pharmaceuticals but also in methods for molecular biology techniques.

US Patent:

60176970, Jan 25, 2000

Filed:

Nov 14, 1994

Appl. No.:

8/337797

Inventors:

James Paul Burnett - Indianapolis IN
Nancy Gail Mayne - Indianapolis IN
Robert Leon Sharp - Indianapolis IN
Yvonne Marie Snyder - Indianapolis IN

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

C12Q 168

US Classification:

435 6

Abstract:

This invention describes a novel human glutamate receptors, designated mGluR2. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.

US Patent:

63132796, Nov 6, 2001

Filed:

Dec 22, 1993

Appl. No.:

8/172332

Inventors:

J. Paul Burnett - Indianapolis IN
Nancy G. Mayne - Indianapolis IN
Robert L. Sharp - Indianapolis IN
Yvonne M. Snyder - Indianapolis IN

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

C12N 1512
C07K 14705

US Classification:

536 235

Abstract:

The present invention provides a human glutamate receptor and related DNA compounds useful not only in assays for potential pharmaceuticals but also in methods for molecular biology techniques.

US Patent:

63037513, Oct 16, 2001

Filed:

Oct 3, 1995

Appl. No.:

8/538526

Inventors:

J. Paul Burnett - Indianapolis IN
Nancy G. Mayne - Indianapolis IN
Robert L. Sharp - Indianapolis IN
Yvonne M. Snyder - Indianapolis IN

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

C12N 1512
C07K 14705

US Classification:

530350

Abstract:

This invention provides a human glutamate receptor and functional equivalents thereof, and nucleic acids compounds which encode the receptor. The invention also provides assays, probes and primers, and other molecular biology techniques which utilize the compounds disclosed.

US Patent:

20210095483, Apr 1, 2021

Filed:

Oct 1, 2019

Appl. No.:

16/589493

Inventors:

- Chicago IL, US
Jeffrey Robert Hillis - Everett WA, US
Steven Edwin May - Everett WA, US
Robert Tyler Sharp - Marysville WA, US

International Classification:

E04G 5/04
B64C 1/10
E04G 7/14

Abstract:

A method and apparatus for assembling a hanging scaffold system within the aft pressure bulkhead area of an aircraft to provide access to the pressure dome without contacting the pressure dome. The hanging scaffold system comprises a group of horizontal supports to support at least one floorboard. A group of vertical supports is connected to and extends perpendicularly from the group of horizontal supports. A clamping device is attached to each vertical support of the group of vertical supports and further engages an attachment point on an internal structure of an aircraft.